1
ALL1
Granules India LimitedYear
1
ALL1
2020DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
INDIA1
ALL1
InapplicableTherapeutic Area
1
ALL1
NeurologyStudy Phase
1
ALL1
Approved FDFDeal Type
1
ALL1
InapplicableProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
UndisclosedLead Product
1
ALL1
Naproxen SodiumTarget
1
ALL1
COXLead Product(s) : Naproxen Sodium,Diphenhydramine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Receives FDA Approval for Naproxen Sodium/Diphenhydramine Tablets
Details : Generic of Naproxen Sodium and Diphenhydramine HCl Tablets are approved for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep.
Product Name : Aleve-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 25, 2020
Lead Product(s) : Naproxen Sodium,Diphenhydramine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable